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ABSTRACT 
Objective: The aim of this research work was to comparatively study various proportions of a natural hydrocolloid-Raphia africana, and 
polyvinylpyrrolidone (PVP) as release sustaining agents in diclofenac sodium tablet formulation.  
Methods: The purified hydrocolloid (R. africana) was characterized by evaluating its organoleptic, physicochemical and flow properties. Diclofenac-
polymer ratios of 1:0, 1:0.2, 1:0.4, 1:0.6, and 1:0.8 were employed to produce different granule batches using wet granulation method (that is, the 
drug was formulated with 0, 5, 10, 15 and 20 % w/w of either R. africana hydrocolloid or PVP, and coded DWB-00, DRA-05, DRA-10, DRA-15, DRA-
20, DPP-05, DPP-10, DPP-15 and DPP-20, respectively). Flow properties of granules were studied by determining bulk density, tapped density, 
Carr’s index, and Hausner’s ratio for all the formulations. Compressed tablets were evaluated using various parameters as weight variation, 
friability, hardness, tablet thickness and diameter, content uniformity and in vitro dissolution evaluated in phosphate buffer (pH 7.3).  
Results: Flowability, mechanical and release parameters determined were within pharmacopoeial limits. Generally, the values of bulk and tapped 
densities increase as binder concentrations increase for both PVP and R. africana hydrocolloid. The values were significantly different across the 
batches (p<0.05). Hardness values obtained varied significantly (p<0.05) and were between 5 and 12 KgF which imply that most of the tablet 
batches are harder than normal depending on the proportion of the polymer used. All the batches exhibited friability within the standard limit 
without significant difference in values (p>0.05), indicating that tablet formulated with the experimental binders would not undergo surface 
abrasion. All the formulations exhibited zero order kinetics except batches DPP-10 and DPP-15 which showed Higuchi mechanism. Formulation 
batches DRA-05 and DRA-10 showed maximum drug release of 98% and 95% respectively after 6 h. A prolonged drug release was observed on 
increasing polymer ratio. Significantly higher release rates (p<0.05) were observed in the tablets formulated with PVP than those containing R. 
africana gum. All the batches followed non-fickian diffusion release mechanism.  
Conclusion: From the study, purified R. africana hydrocolloid generally appeared to perform better than PVP as sustained release agent. 
Keywords: R. africana hydrocolloid, Diclofenac sodium, Sustained release, Zero order kinetics 




The sustained release pharmaceutical delivery system is formulated to 
retard the release of a therapeutic agent such that its appearance in 
the systemic circulation is delayed and/or prolonged and its plasma 
profile is sustained in duration [1]. This duration is in hours for oral 
dosage forms and varies from days to months in the case of parenteral 
products. According to some researchers, the basic rationale of 
sustained release drug delivery system development is to optimize the 
bio-pharmaceutical, pharmacokinetic and pharmaco-dynamic 
properties of a drug so as to achieve and maintain a constant drug 
blood level such that its utility is maximized, side effects are reduced 
and the cure of the disease is achieved [2-4] Employment of prolonged 
release formulation as supposed to conventional immediate release 
ones has been a widely accepted approach as it would afford the 
patient better compliance and enhanced bioavailability [5, 6].  
Recently, polymers of plant origin have attracted tremendous interest 
due to their wide application as pharmaceutical adjuvants such as 
diluents, binders, disintegrants, thickeners, protective colloids as well 
as gelling agents. These natural hydrocolloids and mucilage are 
preferred to the synthetic ones because they are non-prohibitive, bio-
compatible, and readily available than the latter. Moreover, the natural 
excipients are relatively non-toxic, non-irritant, possesses soothing 
effects and more readily available than the synthetic and semi-
synthetic ones [7]. For instance, the choice of a suitable binder for a 
tablet formulation requires extensive knowledge of the binder 
properties for enhancing the strength of the tablet and also the 
interaction between the various materials constituting a tablet [8]. 
Raphia palm which belongs to the large family, Arecaceae, is a genus of 
about twenty species native to tropical regions of Africa and especially 
Madagascar with one species (R. teadigra) also occurring in Central 
and South Africa. They grow up to 16 m tall with basically clustered 
stems and long leaves, and are remarkable for their compound pinnate 
leaves, the longest in the plant kingdom. The plants are either 
monocarpic, flowering once and then drying after the seeds are 
mature, or hypoxanthic, with individual stems dying after fruiting but 
the root system remaining alive and sending up new stems [9, 10].  
Diclofenac is the most widely used of non-steroidal anti-inflammatory 
drugs (NSAIDs) in the treatment of rheumatic disorders. The name 
diclofenac is derived from its chemical name: 2-(2, 6-dichloranilino) 
phenylacetic acid [11]. The drug has been shown to inhibit the 
lipoxygenase pathways thereby reducing the formation of the 
leukotriene. As part of its mode of action, diclofenac may also inhibit 
phospholipase A2 [12]. It is characterized by rapid systemic clearance, 
and thus warrants the use of sustained release formulation for 
prolonged action and to improve efficacy [13]. Also, the various 
experimental reports such as solubility, pH and half-life indicated 
diclofenac as a good candidate for sustained release formulation.  
A thorough literature search showed that R. africana hydrocolloid, 
though possesses good binding properties in conventional tablets 
[14], its activity as a release sustaining agent has not been evaluated. 
Thus, this study was primarily designed to formulate sustained 
release diclofenac sodium tablet with R. africana hydrocolloid as a 
binder and assess its dosage sustainability, using such parameters as 
weight variation, friability, hardness, tablet thickness and diameter, 
content uniformity and dissolution test. 
MATERIALS AND METHODS 
Materials 
The materials used are diclofenac sodium powder (Sigma-Aldrich, 
USA), polyvinylpyrrolidone (PVP) (FSA Lab Supplies, England), talc 
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powder, lactose, maize starch (BDH Chemicals Ltd, Poole, UK), 
magnesium stearate (Sigma-Aldrich, USA), Raffia gum was extracted 
and purified in the Pharmaceutical Technology Laboratory, 




Raphia gum was obtained from the incised trunk of R. africana palm at 
a village in Uyo Local Government Area of Akwa Ibom State, Nigeria. 
The plant was authenticated in the herbarium facility of the Faculty of 
Pharmacy, University of Uyo, Nigeria and the voucher number of 
authentication is UUPH8 (eii). The gum was purified using an 
established procedure [10, 15, 16]. The raw Raffia gum was hydrated 
in 0.5: 95.5 (v/v) chloroform water mixture for 5 d with intermittent 
stirring; extraneous materials were removed by straining through a 
piece of calico cloth. The gum was precipitated from solution using 
absolute ethanol. The precipitated gum was filtered washed with 
diethyl ether and then dried in hot air oven at 40 °C for 18 h. The dried 
gum was pulverized using a laboratory blender (Neelam Industries, 
India). The extracted gum was screened to obtain fines (<180 µm) and 
the percentage yield of the gum then computed. 
Physicochemical properties 
Moisture content and pH 
The moisture content of the purified gum was determined by 
employing an Ohaus moisture balance (Ohaus Scale Corporation, 
USA). The pH of the supernatant liquid obtained after shaking a 2 g 
quantity of the gum powder with 100 ml of distilled water for 5 min 
was determined using a pH meter (Kent Industrial Measurements, 
England).  
Swelling index 
The swelling index of the gum sample was determined by the 
method employed by some workers [17, 18]. A quantity (1 g) of the 
powdered and dried sample was poured into 15 ml plastic 
centrifuge tubes and the volume occupied was recorded (V1). Ten 
milliliters (10 ml) of distilled water was added and stoppered. The 
dispersion was mixed on a vortex mixer (Vortex Gennie Scientific, 
USA) for 2 min and then allowed to stand for 10 min and thereafter 
immediately centrifuged at 1000 rpm for 10 min on a centrifuge 
(GallenKamp, England). The supernatant was decanted and the 
volume of sediment obtained (V2). The swelling index was then 
calculated as follows:  
Swelling index =  V2V1 R…………… (1) 
Water absorption capacity (WAC)  
To 2.5 g of gum sample in a weighed 50 ml centrifuge tube, 30 ml of 
distilled water was added. This was then agitated on a vortex mixer 
for 2 min, centrifuged at 400 rpm for 20 min (Optima Centrifuge, 
Type BHG 500, Germany) and the supernatant carefully decanted. 
The residue was weighed (W1). The adsorbed drops of water were 
removed by drying the residue at 60 °C to constant weight (W2
The fixed funnel and free-standing cone method [20-22] was 
employed to determine the static angle of repose of the purified 
gum. A glass funnel was clamped on a retort stand with its tip 2 cm 
above a plain white sheet of paper, placed on a flat horizontal 
surface. A 30 g quantity of the powder was carefully poured through 
the funnel until the apex of the cone-shaped heap thus formed by the 
powder just reached the tip of the funnel. The height of the sample 
(H) was obtained using a cathetometer. The diameter (D) of the 
static base was divided by two to obtain the radius R. Angle of 
repose (Ɵ) for the gum was then calculated using the equation:  
Ɵ =  tan
−1 H
R
 …………… (3) 
Flow rate  
The flow rate was determined by clamping a clean dry funnel on a 
retort stand at a fixed position such that its lower tip was 8 cm 
above a piece of plain white sheet of paper placed on the horizontal 
bench surface directly under the funnel tip. The orifice of the funnel 
was blocked at the tip and 30 g of the gum powder was accurately 
weighed into the funnel. The bottom of the funnel was unblocked 
and the time taken for the entire sample to flow out of the funnel 
was taken. The flow rate was then determined as the mass of the 
sample per unit time (g/s). 
Bulk and tapped densities 
A 25 g quantity of the gum powder was placed in a 100 ml clean, dry 
measuring cylinder and the volume V
) in 
an oven. WAC was then expressed as the weight of water bound by 
100 g dry gum powder [19]: 
WAC =  [(W1–W2)
2.5
].100 …………… (2) 
Evaluation of flow and density properties of purified gum  
Angle of repose 
b occupied by the sample 
without tapping was determined. After some mechanical taps of the 
cylinder on a padded horizontal surface, the tapped volume Vt was 
recorded (when a constant volume was reached). The means of four 
determinations was taken. The bulk and tap densities, Dband Dt  
(g/cm3) were calculated as the ratio of sample weight to volume (V0 
and Vt respectively) [22]. 
Hausner’s index  
The Hausner’s index was calculated as the ratio of the tapped 
density to the bulk density of the sample, that is, 
Hausner’s index = Dt
Db
R 
Carefully weighed magnesium stearate (0.2 g) and talc (0.2 g) were 
mixed with each batch of granule in a sample bottle and then 
transferred into a beaker. Each tablet of 400 mg was compressed using 
a single punch tabletting machine (SSF-3) (Cadmach machinery CO. 
PVT. Ltd; India) at a compression pressure of 35 kN. Each batch of 
tablets produced was then stored in an airtight container for further 
analysis. 
…………… (4) 
Carr’s compressibility index (CI %) 
The value of CI was computed by employing the following equation:  
CI % = Dt−Db
Dt
.100 …………… (5) 
Preparation of diclofenac granules 
Diclofenac sodium granule preparation was carried out based on the 
following formula:  
Diclofenac sodium-100 mg Polymer-x % Magnesium stearate-1 % 
Talc-1 % Corn starch-5 % Lactose-q. s 
NOTE: x ranges from 0–20 % 
Each batch of 20 g of granule was prepared by incorporating either 
Raphia gum extract or PVP as a binder at 5%, 10%, 15% and 20% with 
other ingredients as presented in table (1). Appropriate quantities of 
diclofenac sodium, cornstarch and lactose were weighed out and 
mixed using mortar and pestle to obtain a homogenous mix. Then an 
appropriate amount of the binder (Raphia gum) was dispersed in a 
small quantity of hot water and was used to granulate the 
homogenous powder mixture in the mortar to form a damp coherent 
mass. The wet mass was passed through a 2.0 mm stainless steel sieve 
with the aid of a spatula. The wet granules were dried in the hot air 
oven at a temperature of 50 °C for about an hour after which they 
were further passed through the 1.0 mm stainless steel sieve to obtain 
finer granules. This was repeated for the different batches varying the 
ingredients based on the formula in the table (1).  
Evaluation of the flow and density properties of diclofenac 
sodium granules 
Various flow and density characteristics for all the batches of 
prepared granules–angle of repose, flow rate, bulk and tapped 
densities, Hausner’s ratio and Carr’s index–were evaluated using the 
same methods as earlier explained for purified gum powder. 
Preparation of tablets 
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 Table 1: The basic formula for the preparation of sustained release diclofenac sodium tablet containing 100 mg of the drug per unit 
Ingredients DWB-00 DRA-05a DRA-10b DRA-15b DRA-20b DPP-05b DPP-10c DPP-15c DPP-20c c 
Diclofenac Na 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 100 mg 
Raffia gum − 20 mg 40 mg 60 mg 80 mg − − − − 
PVP − − − − − 20 mg 40 mg 60 mg 80 mg 
Magnesium stearate 4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 
Talc  4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 4 mg 
Starch  20 mg 20 mg 20 mg 20 mg 20 mg 20 mg 20 mg 20 mg 20 mg 
Lactose  272 mg 252 mg 232 mg 212 mg 192 mg 252 mg 232 mg 212 mg 192 mg 
Total 400 mg 400 mg 400 mg 400 mg 400 mg 400 mg 400 mg 400 mg 400 mg 
aDWB-00 is diclofenac tablet formulation without binder (that is, 0.0% binder), bDRA are diclofenac tablet formulations containing R. africana gum 
binder at concentrations of 05, 10, 15 and 20 %w/w, c
 
Evaluation of tablet physicomechanical properties 
Tablet dimensions  
The diameter and thickness of ten tablets from the different batches 
were determined using a micrometre screw gauge (0.25x0.01 mm). 
The average values were then computed for each batch [23]. 
Weight uniformity 
Twenty tablets were obtained from each of the batches and weighed 
individually with an electronic analytical weighing balance (Ohaus 
Scale Corporation, USA). The mean weight and standard derivation 
were determined for each tablet batch to establish whether or not it 
conforms to the official weight uniformity standards [23, 24]. 
Hardness test 
Tablet hardness was determined using the Monsanto hardness 
tester, India (MHT-20). Ten tablets from each batch were used. Each 
tablet was placed diametrically between the jaws of the tester and 
the force needed to just crush the tablet was noted. The mean of the 
hardness was also determined [23, 25]. 
Friability test  
Ten tablets from each batch were obtained, de-dusted, weighed and 
placed in separate drums of a Roche friabilator (DT-2D). The tablets 
were tumbled for 4 min at a speed of 25 revolutions per minute. The 
tablets were then removed, de-dusted and weighed again. The 
friability of the tablets was expressed as a percentage using the 
formula below [23, 25]. 
Friability = weight loss 
original weight
 ×100 …………. (6) 
Tablet dissolution and release kinetics studies 
DPP are diclofenac tablet formulations containing polyvinylpyrrolidone (PVP) binder at 
concentrations of 05, 10, 15 and 20 % w/w. 
In vitro dissolution test for the tablets was carried out using the 
United States Pharmacopoeia basket method in the tablet 
dissolution test apparatus [26]. The tablet was placed in a wire mesh 
basket suspended in a dissolution medium of 900 ml of dissolution 
medium containing 2.1 %w/v of citric acid and pH phosphate buffer 
maintained at 37±1℃ in a water bath. The wire mesh basket was 
rotated at a speed of 50 rpm. The experiment was allowed to run for 
6 h and 10 ml aliquot withdrawn at 30 min intervals filtered through 
Whattman filter paper No.2 and assayed spectrophotometrically 
using the UV 2100 spectrophotometer. The assayed was done at a 
wavelength of 276 nm where diclofenac experiences peak 
absorption. An equal volume of fresh medium was replaced into the 
dissolution medium after each sampling to maintain the constant 
volume throughout the test. The concentration of the active 
ingredient was then obtained from the standard Beer Lambert’s plot. 
The data obtained from the dissolution studies were fitted into the 
release kinetics of Zero order, First order, Higuchi and Korsmeyer 
equations using the model dependent methods [27, 28]. 
Content uniformity test 
Ten tablets were selected randomly from each batch and powdered. 
A quantity of this powder corresponding to 100 mg of diclofenac 
sodium was dissolved in 100 ml of 7.3 pH phosphate buffer stirred 
for 60 min and filtered. A quantity of 1 ml of the filtrate was diluted 
to 100 ml with the phosphate buffer. The absorbance of this solution 
was measured at 276 nm and content of diclofenac sodium was 
estimated [26, 29].  
All the determinations were made in quadruplicates and the values 
presented were the average values (±standard deviations). 
Statistical evaluation  
All determinations were carried out in quadruplicates (n = 4). Values 
of parameters were presented as mean±SD. Statistical evaluation 
was performed by employing a two-way Analysis of Variance 
(ANOVA) on a computer software GraphPad Prism® 4 (GraphPad 
Software Inc., San Diego, USA). Post-hoc (Turkey-Kramer multiple 
comparison) tests was used in comparing the individual differences 
between the samples. At 95 % confidence interval, probability (p) 
values less than 0.05 were considered statistically significant. 
RESULTS AND DISCUSSION 
The pure gum obtained from R. africana exudates was 30.4 %w/w. 
From the result obtained from the evaluation of gum powder flow 
(table 2), it was found that the flow rate, Carr’s index, Hausner’s 
ratio and angle of repose had values that comply with the official 
standard for good powder flowability. 
 
Table 2: Flow properties of purified R. africana hydrocolloid 
Parameters R. africana hydrocolloid 
Angle of repose ( °)  39.60±𝟏𝟏.𝟗𝟗𝟗𝟗 
Flow rate (g/sec)  1.90±𝟗𝟗.𝟏𝟏𝟗𝟗 
Bulk density (g/ml)  0.68±𝟗𝟗.𝟗𝟗𝟎𝟎 
Tapped density (g/ml)  0.88±𝟗𝟗.𝟗𝟗𝟎𝟎 
Carr’s index (%)  22.72±𝟏𝟏.𝟏𝟏𝟏𝟏 
Hausner’s ratio  1.29±𝟗𝟗.𝟗𝟗𝟎𝟎 
Data presented are as mean values±SD, n = 4 
 
The values of physicochemical properties (moisture content, pH, 
swelling index, water absorption capacity and moisture sorption 
capacity) determined for the hydrocolloid are presented in table (3). The 
values indicate not only that the performance of the experimental 
hydrocolloid as excipient would be enhanced; it is also suggestive of its 
compatibility with other components of the formulation [10, 14]. 
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Table 3: Physicochemical properties of purified R. africana hydrocolloid 
Parameters R. africana hydrocolloid 
Moisture content (%)  7.20±𝟗𝟗.𝟑𝟑𝟑𝟑 
pH  6.79±𝟗𝟗.𝟑𝟑𝟎𝟎 
Swelling index   3.95±𝟗𝟗.𝟎𝟎𝟗𝟗 
Water absorption capacity (g/100 g)  78.00±𝟎𝟎.𝟏𝟏𝟑𝟑 
Moisture sorption capacity (%) 102.50±𝟑𝟑.𝟎𝟎𝟎𝟎 
Data presented are as mean values±SD, n = 4 
 
The pre-compression evaluation of flowability and densification of 
the formulated granules equally depict good flow (as shown in table 
4). The higher the concentrations of either PVP or R. africana 
hydrocolloid, the higher were the values of bulk and tapped 
densities. Generally, as the size of granules increases, the orifice 
would be blocked and the flow retarded. 
  
Table 4: Flow and density properties of sustained release diclofenac Na formulated with R. africana gum and PVP binders 
Batches  Angle of repose Flow rate (g/s) Bulk density (g/cm3 Tapped density (g/cm) 3 Hausner’s ratio ) Carr’s index 
DWB-00 21.80±1.00  5.38±0.18  0.525±0.020  0.589±0.011  1.12±0.018  10.86±1.01 
DRA-05 26.56±1.09  5.35±0.20  0.550±0.018  0.623±0.028  1.13±0.028  11.72±0.91  
DRA-10 25.27±1.22  6.33±0.21  0.625±0.021  0.690±0.025  1.10±0.026  10.40±0.75  
DRA-15 26.56±2.02  6.05±0.21  0.635±0.030  0.733±0.026  1.15±0.031  15.43±2.00  
DRA-20 25.64±1.26  6.11±0.09  0.645±0.015  0.688±0.028  1.06±0.022   6.66±0.88  
DPP-05 25.94±1.25  5.84±0.18  0.545±0.022  0.597±0.019  1.09±0.045   9.54±0-90  
DPP-10  30.39±2.41  4.64±0.02  0.484±0.012  0.553±0.015  1.14±0.019  14.25±2.01  
DPP-15  29.55±2.50  5.20±0.03  0.546±0.020  0.600±0.022  1.09±0.033   9.89±1.04  
DPP-20  25.90±2.52  7.14±0.02  0.623±0.022  0.723±0.020  0.86±0.017  16.05±1.08  
Data presented are as mean values±SD, n = 4 
 
Mechanical properties of the compressed tablets are presented in 
table (5). The thickness and diameter of a tablet al. so play a key part 
in dose uniformity. The diameter size and shape of tablet depend on 
the die and punches selected for making the tablet. From the values 
of tablet dimensions determined, the tablets generally exhibited 
uniform diameter and conform to the limits for tablets. Tablet 
thickness is an important quality control test for tablet packaging. 
Tablet thickness may influence ease of packaging either in blisters or 
plastic containers. Tablet thickness can vary without any change in 
its weight. This may depend on the die size of the tablet machine as 
well as the force applied to compress the powder. It can also be 
influenced by the different density of granules and the speed of 
compression. From the result, the tablets exhibited good uniformity 
of thickness and conform to the official standard limit. 
The uniformity of weight of tablets contributes to the dose 
uniformity of a drug [26]. The data obtained for weight uniformity 
test indicate that the tablets possess significant dose uniformity. 
Variations in tablet weight may be due to inconsistent powder or 
granule density and particle size distribution. 
Official hardness values for conventional immediate release tablets 
range from 4-6 kgF but 5-8 kgF for sustained release tablets [7, 26, 30]. 
From the study, the hardness obtained ranges from 5-12 kgF which 
imply that most of the tablet batches are harder than normal. This 
difference in hardness may be due to the quantity of the polymer 
used. There was significant variation (p<0.05) observed between the 
hardness values between the tablets formulated with either of the 
two binders. Tablet hardness influences the rate of release of drug 
during dissolution test. If a tablet is too hard, it may be difficult to 
dissolve during dissolution test and soft tablet cannot withstand the 
pressure force applied to it. The nature of the polymer used as 
binder influences the hardness of tablets. Hardness influences 
compaction and tablets with high compaction have a high ability to 
retard solvent penetration into the tablet core.  
All the formulated tablets had friability within the official limits of 
≤ 1% [30], and the difference between the values was statistically 
insignificant (p>0.05). Indicating that tablet formulated with the 
experimental binders would. Friability test measures the ability of 
tablets to withstand abrasion during packaging, handling, and 
shipping. The normal limit for friability is less or equal to Lower 
values observed implies that the tablet would not readily undergo 
surface abraision upon handling. All the batches complied with the 
standard requirement for uniformity of active ingredient. That is, 
diclofenac content of the tablets was relatively uniform for most of 
the batches and statistically, there was generally no significant 
difference in the drug content across the batches (p>0.05). Thus, 
when such tablets are administered, no dose variation is expected 
[26]. 
 
Table 5: Mechanical parameters of diclofenac Na tablets formulated with with R. africana gum and PVP binders 
Batch  Weight variation (g) Hardness (kgF)  Friability (%)  Diameter (mm)  Thickness (mm)  Drug content (%)  
DWB-00 0.40±0.02 4.45±0.39 1.11±0.01 12.51±0.02 2.56±0.04 82.67±9.5 
DRA-05 0.40±0.01 8.20±0.24 0.43±0.01 12.50±0.02 2.57±0.01 80.00±8.5 
DRA-10 0.40±0.01 9.30±0.21 0.45±0.02 12.53±0.02 2.58±0.12 77.33±2.4 
DRA-15 0.40±0.01 10.25±0.24 0.20±0.01 12.55±0.01 2.58±0.04 73.50±8.4 
DRA-20 0.40±0.02 5.85±0.23 0.23±0.01 12.50±0.02 2.54±0.01 72.83±2.6 
DPP-05 0.40±0.01 6.85±0.23 0.45±0.01 12.50±0.05 2.53±0.02 83.00±7.7 
DPP-10 0.41±0.03 6.85±0.23 0.22±0.01 12.50±0.02 2.52±0.01 80.00±9.5 
DPP-15 0.40±0.01 5.58±0.21 0.22±0.01 12.55±0.01 2.52±0.01 76.32±7.8 
DPP-20 0.40±0.01 10.65±0.23 0.45±0.01 12.55±0.01 2.53±0.02 75.15±5.9 
Data presented are as mean values±SD, n = 4. 
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Fig. 1: Plots of percentage diclofenac released against time for tablets containing 5 % w/w and 20 %w/w of R. africana hydrocolloid and 
PVP as binders, n = 4; the graph was plotted from mean values of four (4) determinations 
 
Table 6: Release kinetics for diclofenac tablets 
Batches Zero-order First order Higuchi Korsmeyer n (diffusion) 
DWB-00 0.961 0.702 0.906 0.877 0.54 
DRA-05 0.984 0.974 0.992 0.975 0.58 
DRA-10 0.990 0.977 0.986 0.964 0.65 
DRA-15 0.998 0.964 0.970 0.949 0.71 
DRA-20 0.996 0.975 0.967 0.947 0.73 
DPP-05 0.992 0.750 0.977 0.954 0.52 
DPP-10 0.979 0.894 0.994 0.976 0.62 
DPP-15 0.971 0.967 0.995 0.970 0.68 
DPP-20 0.994 0.962 0.988 0.973 0.72 
 
From the results obtained for dissolution test, plots were made of 
percentage diclofenac released against time for all the tablets 
containing R. africana hydrocolloid and PVP as binders. Typical plots 
for tablets formulated with 5 %w/w and 20 % w/w of the binders 
are presented in fig. (1). Values obtained when data from dissolution 
studies were fitted into the equations of Zero order, First order, 
Higuchi and Korsmeyer are as shown in the table (6). Batches DWB-
00, DRA-05, DRA-10, DRA-15, DRA-20, DPP-05, and DPP-20 showed 
zero order kinetics meaning that diffusion in these batches was 
independent of the initial concentration of drug in the dissolving 
medium. Two batches of the formulations containing synthetic 
polymer-DPP-10 and DPP-15 showed Higuchi kinetics. Therefore R. 
africana gum is a good choice for sustained release formulations, 
thus confirming the findings of Bhosale and co-workers that natural 
hydrocolloids are effective alternative binders to synthetic ones in 
the formulation of sustained release tablets [29]. The release rates 
shown by tablets containing PVP were significantly higher (p<0.05) 
than those exhibited by those containing R. africana hydrocolloid. 
The mechanism of release for all the batches followed non-fickian 
diffusion. 
Batches formulated with polyvinylpyrrolidone (PVP) showed higher 
release than those formulated with R. africana gum. This may be due 
to slow hydration of matrix and its property to form a gel layer 
which retards the drug release from the tablet. Highest release of the 
polymer (Raffia gum) was obtained in batch DRA-05 with 98 % and 
DRA-10 with 95 % release. The highest release for the synthetic 
binder (PVP) was obtained in batches DPP-05, at 110 %, 103 % and 
96%, respectively. 
The results obtained indicate that the batches complied with the 
standard requirements for uniformity of active ingredients. This 
implies that the tablets contain a relatively uniform amount of active 
ingredient (diclofenac). As a result, the tablets would exhibit 
uniform potency which characterizes a positive content uniformity 
test result. 
CONCLUSION 
From the study, the use of Raphia gum as a binder in formulating 
sustained release diclofenac tablet was satisfactory based on 
compliance with official standards. All the formulations containing 
the natural gum exhibit sustained release with formulation DRA-20 
containing 20 % of the gum found to release the drug in a slow, 
controlled manner with maximum drug release of 83% after 6 h. 
This implies that the percentage of drug release decreases with 
increasing polymer content. The rate of release for the synthetic 
polymer (PVP) was much higher than for the natural polymer 
(Raphia gum) thereby making Raphia gum a better candidate for 
sustained release formulation. The kinetics of drug release from the 
tablets followed zero order with non fickian diffusion mechanism. 
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